Discontinuation report CIPRO XL

Last updated on 2022-03-02 History
Report ID 153198
Drug Identification Number 02247916
Brand name CIPRO XL
Common or Proper name CIPROFLOXACIN
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 50'S
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-01-31
Actual discontinuation date 2022-03-01
Remaining supply date 2022-01-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-20 English Compare
v2 2022-01-20 French Compare
v3 2022-03-02 English Compare
v4 2022-03-02 French Compare

Showing 1 to 4 of 4